GMO Pepabo, Inc. AI Stock Analysis
Want to see JP:3633 full AI Analyst Report?
GMO Pepabo, Inc. (3633) AI Stock Analysis
GMO Pepabo, Inc.
(TSE/TYO:3633)
The overall score of 69 reflects a company with strong fundamentals and an attractive valuation, offset by weak near-term price momentum. The company's excellent balance sheet, high cash generation, and improved profitability are the most significant positive factors. The very low P/E ratio and high dividend yield further enhance the investment case. However, the stock is currently in a technical downtrend, trading below key moving averages with negative momentum, which presents a significant headwind and prevents a higher score.
GMO Pepabo, Inc. (3633) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 11.74B
- Dividend Yield
- 4.80%
- Average Volume (3M)
- 30.10K
- Price to Earnings (P/E)
- 8.3
- Beta (1Y)
- 0.59
- Revenue Growth
- -3.24%
- EPS Growth
- 80.65%
- Country
- Japan
- Employees
- 307
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Infrastructure
GMO Pepabo, Inc. Business Overview & Revenue Model
Company Description
GMO Pepabo, Inc. delivers a variety of internet-based services tailored for individual consumers across Japan. The firm organizes its activities into four core divisions. Its Hosting segment supplies foundational services, including domain registrati...
GMO Pepabo, Inc. Financial Statement Overview
Summary
Strong overall financial health driven by a robust balance sheet (Score 87) and solid cash flow generation (Score 82). Profitability has improved significantly, with record net margins and high ROE. The primary offset is stagnant revenue growth, which tempers the otherwise excellent financial profile.
Income Statement
68PositiveBalance Sheet
87Very PositiveCash Flow
82Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.83B | 10.96B | 10.92B | 10.90B | 10.53B | 11.88B |
| Gross Profit | 5.84B | 5.96B | 5.78B | 5.93B | 6.08B | 6.73B |
| EBITDA | 1.68B | 1.44B | 1.47B | 84.16M | 1.12B | 1.36B |
| Net Income | 829.77M | 878.44M | 591.63M | -628.79M | 510.09M | 715.41M |
Balance Sheet | ||||||
| Total Assets | 10.67B | 11.32B | 11.47B | 10.95B | 11.52B | 8.91B |
| Cash, Cash Equivalents and Short-Term Investments | 2.02B | 5.75B | 4.92B | 4.36B | 3.61B | 3.62B |
| Total Debt | 400.00M | 857.45M | 1.19B | 1.48B | 1.57B | 172.15M |
| Total Liabilities | 8.24B | 8.52B | 9.08B | 9.14B | 8.83B | 5.96B |
| Stockholders Equity | 2.43B | 2.80B | 2.39B | 1.81B | 2.69B | 2.93B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.37B | 901.23M | 1.38B | -708.88M | 338.84M |
| Operating Cash Flow | 0 | 1.46B | 1.21B | 1.78B | -213.40M | 669.08M |
| Investing Cash Flow | 0 | 236.62M | -292.00M | -325.63M | -510.15M | -278.35M |
| Financing Cash Flow | 0 | -859.23M | -361.39M | -702.63M | 712.28M | -392.52M |
GMO Pepabo, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3633, the sentiment is Neutral. The current price of 2314.00 is below the 20-day moving average (MA) of 2375.30, below the 50-day MA of 2509.40, and above the 200-day MA of 2047.69, indicating a neutral trend. The MACD of -54.54 indicates Negative momentum. The RSI at 43.43 is Neutral, neither overbought nor oversold. The STOCH value of 72.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3633.
GMO Pepabo, Inc. Peers Comparison
Overall Rating
JP:443181Outperform
JP:376973Outperform
JP:443471Outperform
JP:363369Neutral
JP:377847Neutral
JP:366546Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 81Outperform | JPY 62.90B | 24.42 | ― | 0.75% | 20.70% | 56.44% | |
| 73Outperform | JPY 637.38B | 25.41 | 20.84% | 2.23% | 15.40% | 14.93% | |
| 71Outperform | JPY 24.01B | 20.43 | ― | 1.33% | 23.79% | ― | |
| 69Neutral | JPY 12.24B | 8.34 | ― | 4.80% | -3.24% | 80.65% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 47Neutral | JPY 115.46B | 42.09 | ― | 0.17% | 25.84% | 71.45% | |
| 46Neutral | JPY 16.74B | 68.83 | ― | 7.46% | -1.71% | -7.98% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3633 | GMO Pepabo, Inc. | 2314.00 | 252.39 | 12.24% | |
| JP:3769 | GMO Payment Gateway | 8404.00 | -923.18 | -9.90% | |
| JP:3665 | ENIGMO, Inc. | 402.00 | 33.06 | 8.96% | |
| JP:3778 | SAKURA Internet Inc. | 2888.00 | -96.30 | -3.23% | |
| JP:4431 | Smaregi, Inc. | 3215.00 | 524.13 | 19.48% | |
| JP:4434 | Serverworks Co., Ltd. | 3015.00 | 1273.73 | 73.15% |
GMO Pepabo, Inc. Corporate Events
GMO Pepabo Announces Holding Company Plan and GMO MAKESHOP Discussions
On November 13, GMO Pepabo said its board had resolved to establish GMO AI Commerce Holdings through a sole-share transfer and pursue a holding company structure. It also began discussions with parent GMO Internet Group and GMO MAKESHOP concerning a...
GMO Pepabo Reports Nine-Month Sales Decline, Operating Profit Rise
GMO Pepabo reported net sales of ¥8,025 million for the nine months ended September 30, 2026, down 2.9% from a year earlier, while operating profit rose 2.0% to ¥806 million and ordinary profit fell 16.6% to ¥872 million. Profit attributable to owner...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
